Diabetes
Article
Why are we doing cardiovascular outcome trials in type 2 diabetes?
Lowering blood glucose alone may not reduce adverse cardiovascular events.
News
Dapagliflozin-metformin combination tablet approved by FDA
News
Metformin linked to less intensification of diabetes treatment
Key clinical point: Metformin as first-line therapy is associated with lower rates of progression, compared with other oral glucose-lowering...
Article
Statin Adverse Effects: Sorting out the Evidence
News
Purified Pollen Extract for Hot Flashes Did Not Inhibit Tamoxifen’s Efficacy
Key clinical point: When SSRIs are contraindicated for treatment of vasomotor symptoms, such as in women taking tamoxifen, Relizen was found to be...
Video
VIDEO: Experts call for tighter regulation of glucose monitoring devices
News
VIDEO: Experts Call for Tighter Regulation of Glucose Monitoring Devices
News
Is the FDA’s Black Box on Estrogen Too ‘Alarming’?
News
Insulin pumps associated with reduced risk of cardiovascular disease
Key clinical point: Insulin pumps may moderate the risk of cardiovascular disease in patients with type 1 diabetes. Major finding: Compared to...
News
Insulin Pumps Associated With Reduced Risk for Cardiovascular Disease
Key clinical point: Insulin pumps may moderate the risk of cardiovascular disease in patients with type 1 diabetes. Major finding: Compared to...